Nephrogenic fibrosing dermopathy: Lessons from the past

International Journal of Dermatology

Volumn 45, Issue 6, 2006, Pages 639-641

  Swaminathan, Sundararaman ^a   Leung, Nelson ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; AMINOLEVULINIC ACID METHYL ESTER; BLOOD CLOTTING FACTOR 8; CALCIUM PHOSPHATE; CD34 ANTIGEN; CD68 ANTIGEN; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; PHOSPHATE BINDING AGENT; PREDNISONE; PROCOLLAGEN; VASCULOTROPIN; VITAMIN D; WARFARIN;

ARTICLE; BLOOD VESSEL INJURY; CALCINOSIS; CALCIUM INTAKE; CLINICAL FEATURE; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG FATALITY; EOSINOPHILIC FASCIITIS; HEMODIALYSIS PATIENT; HISTOPATHOLOGY; HUMAN; HYPERPHOSPHATEMIA; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE; NEPHROGENIC FIBROSING DERMOPATHY; OSTEODYSTROPHY; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PHYSIOTHERAPY; PORPHYRIA CUTANEA TARDA; PUVA; REFRACTORY ANEMIA; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; SCLEREDEMA; SCLEROMYXEDEMA; SKIN BIOPSY; SYSTEMIC SCLEROSIS;

BIOPSY; CALCIPHYLAXIS; DIAGNOSIS, DIFFERENTIAL; FIBROSIS; HUMANS; KIDNEY FAILURE; KIDNEY FAILURE, CHRONIC; SKIN DISEASES;

EID: 33745942538     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2006.02837.x     Document Type: Article

References (24)

1. Cowper SE, Robin HS, Steinberg SM, et al. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 2000; 356: 1000-1001.
2. Cowper SE, Su LD, Bhawan J, et al. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 2001; 23: 383-393.
3. Hauser C, Kaya G, Chizzolini C. Nephrogenic fibrosing dermopathy in a renal transplant recipient with tubulointerstitial nephritis and uveitis. Dermatology 2004; 209: 50-52.
4. Lauchli S, Zortea-Caflisch C, Nestle FO, et al. Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis. Dermatology 2004; 208: 278-280.
5. Tan AW, Tan SH, Lian TY, et al. A case of nephrogenic fibrosing dermopathy. Ann Acad Med Singapore 2004; 33: 527-529.
6. Cowper SE. Nephrogenic fibrosing dermopathy: The first 6 years. Curr Opin Rheumatol 2003; 15: 785-790.
7. Swartz RD, Crofford LJ, Phan SH, et al. Nephrogenic fibrosing dermopathy: A novel cutaneous fibrosing disorder in patients with renal failure. Am J Med 2003; 114: 563-572.
8. LeBoit PE. What nephrogenic fibrosing dermopathy might be. Arch Dermatol 2003; 139: 928-930.
9. Oberg BP, McMenamin E, Lucas FL, et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 2004; 65 (3): 1009-1016.
10. Harper SJ, Downs L, Tomson CR, et al. Elevated plasma vascular endothelial growth factor levels in non-diabetic predialysis uraemia. Nephron 2002; 90: 341-343.
11. Cowper SE, Bucala R. Nephrogenic fibrosing dermopathy: Suspect identified, motive unclear. Am J Dermatopathol 2003; 25: 358.
12. Hubbard V, Davenport A, Jarmulowicz M, et al. Scleromyxoedema-like changes in four renal dialysis patients. Br J Dermatol 2003; 148: 563-568.
13. Mackay-Wiggan JM, Cohen DJ, Hardy MA, et al. Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease). J Am Acad Dermatol 2003; 48: 55-60.
14. Baron PW, Cantos K, Hillebrand DJ, et al. Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis. Am J Dermatopathol 2003; 25: 204-209.
15. Chung HJ, Chung KY. Nephrogenic fibrosing dermopathy: Response to high-dose intravenous immunoglobulin. Br J Dermatol 2004; 150: 596-597.
16. Kafi R, Fisher GJ, Quan T, et al. UV-A1 phototherapy improves nephrogenic fibrosing dermopathy. Arch Dermatol 2004; 140: 1322-1324.
17. Schmook T, Budde K, Ulrich C, et al. Successful treatment of nephrogenic fibrosing dermopathy in a kidney transplant recipient with photodynamic therapy. Nephrol Dial Transplant 2005; 20: 220-222.
18. Smiley CM, Hanlon SU, Michel DM. Calciphylaxis in moderate renal insufficiency: Changing disease concepts. Am J Nephrol 2000; 20: 324-328.
19. Roe SM, Graham LD, Brock WB, et al. Calciphylaxis: Early recognition and management. Am Surg 1994; 60: 81-86.
20. Wilmer WA, Magro CM. Calciphylaxis: Emerging concepts in prevention, diagnosis, and treatment. Semin Dial 2002; 15: 172-186.
21. Fine A, Zacharias J. Calciphylaxis is usually non-ulcerating: Risk factors, outcome and therapy. Kidney Int 2002; 61: 2210-2217.
22. Klemmer PJ. Calcium loading, calcium accumulation, and associated cardiovascular risks in dialysis patients. Blood Purif 2005; 23 (Suppl. 1): 12-19.
23. Goldsmith D, Ritz E, Covic A. Vascular calcification: A stiff challenge for the nephrologist: Does preventing bone disease cause arterial disease? Kidney Int 2004; 66: 1315-1333.
24. Zacharias JM, Fontaine B, Fine A. Calcium use increases risk of calciphylaxis: A case-control study. Perit Dial Int 1999; 19: 248-252.